AMICUS THERAPEUTICS, INC. Balance Sheet
FOLD / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
AMICUS THERAPEUTICS, INC. had $950M in total assets and $274M in shareholders' equity as of FY2025. Total debt was $393M against $214M in cash, resulting in $179M net debt.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -1.19 (distress zone, below 1.8 threshold)
- Negative profit margin: -10.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $214.0M | $213.8M | $247.0M | $148.8M | $245.2M | $163.2M | $142.8M | $79.7M | $49.1M | $187.0M | $69.5M | $24.1M | $43.6M | $34.0M | $25.7M |
| Accounts Receivable | $115.3M | $101.1M | $87.6M | $66.2M | $52.7M | $46.9M | $33.3M | $22.0M | $9.5M | $1.3M | - | - | - | - | - |
| Inventory | $228.8M | $118.8M | $59.7M | $23.8M | $26.8M | $19.6M | $14.0M | $8.4M | $4.6M | $3.4M | $0 | - | - | - | - |
| Current Assets | $676.2M | $504.7M | $483.1M | $423.8M | $596.8M | $579.5M | $520.1M | $551.1M | $392.0M | $340.1M | $216.6M | $154.6M | $88.3M | $104.6M | $66.6M |
| PP&E (Net) | $27.1M | $29.4M | $31.7M | $30.8M | $42.5M | $43.9M | $47.7M | $11.4M | $9.1M | $9.8M | $6.2M | $2.8M | $4.1M | $5.0M | $2.4M |
| Goodwill | $197.8M | $197.8M | $197.8M | $197.8M | $197.8M | $197.8M | $197.8M | $197.8M | $197.8M | $197.8M | $197.8M | $11.6M | $11.6M | - | - |
| Total Assets | $949.9M | $785.0M | $777.9M | $724.2M | $905.1M | $886.5M | $850.2M | $790.0M | $627.0M | $1.0B | $908.4M | $210.0M | $127.6M | $110.1M | $69.8M |
| Current Liabilities | $237.8M | $148.7M | $167.7M | $139.0M | $146.0M | $129.7M | $128.8M | $86.1M | $70.0M | $111.0M | $73.6M | $20.2M | $10.5M | $9.2M | $19.3M |
| Total Debt | $392.7M | $390.1M | $387.9M | $392.0M | $389.4M | $389.3M | $149.5M | - | - | - | - | - | - | - | - |
| Shareholders' Equity | $274.2M | $194.0M | $160.2M | $123.0M | $307.4M | $286.4M | $476.4M | $342.9M | $352.9M | $360.2M | $347.8M | $122.2M | $45.8M | $69.2M | $29.6M |